Drug
Isis 325568
Isis 325568: highest development phase Phase 1, developed by Ionis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Ionis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| ISIS 325568 NCT00519727 | Phase 1 | Type 2 Diabetes Mellitus |
Latest
No recent events.
Follow Isis 325568 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.